Literature DB >> 1986303

HIV and gag.

A S Bourinbaiar.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986303     DOI: 10.1038/349111b0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Efficiency of human immunodeficiency virus type 1 postentry infection processes: evidence against disproportionate numbers of defective virions.

Authors:  James A Thomas; David E Ott; Robert J Gorelick
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

2.  Similar replication capacities of primary human immunodeficiency virus type 1 isolates derived from a wide range of clinical sources.

Authors:  W Lu; J M Andrieu
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection.

Authors:  D R Henrard; S Wu; J Phillips; D Wiesner; J Phair
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

4.  Relationship between frequency of infectious human immunodeficiency virus type 1-harboring cells and kinetics of viral replication: a simple procedure for quantitation of infectious virus-carrying cells in blood samples.

Authors:  W Lu; G Manolikakis; J M Andrieu
Journal:  J Clin Microbiol       Date:  1992-10       Impact factor: 5.948

5.  HIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per Cell.

Authors:  Mikaël Boullé; Thorsten G Müller; Sabrina Dähling; Yashica Ganga; Laurelle Jackson; Deeqa Mahamed; Lance Oom; Gila Lustig; Richard A Neher; Alex Sigal
Journal:  PLoS Pathog       Date:  2016-11-03       Impact factor: 6.823

6.  Inhibitory effect of the oral immune response modifier, bestatin, on cell-mediated and cell-free HIV infection in vitro.

Authors:  A S Bourinbaiar; S Lee-Huang; K Krasinski; W Borkowsky
Journal:  Biomed Pharmacother       Date:  1994       Impact factor: 6.529

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.